IRIS Accounts Production v26.1.0.640 03331962 Board of Directors 1.1.25 31.12.25 31.12.25 8/5/26 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh033319622024-12-31033319622025-12-31033319622025-01-012025-12-31033319622023-12-31033319622024-01-012024-12-31033319622024-12-3103331962ns15:EnglandWales2025-01-012025-12-3103331962ns14:PoundSterling2025-01-012025-12-3103331962ns10:Director12025-01-012025-12-3103331962ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3103331962ns10:SmallEntities2025-01-012025-12-3103331962ns10:Audited2025-01-012025-12-3103331962ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3103331962ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3103331962ns10:AbridgedAccounts2025-01-012025-12-3103331962ns10:OrdinaryShareClass12025-01-012025-12-3103331962ns10:Director22025-01-012025-12-3103331962ns10:Director32025-01-012025-12-3103331962ns10:Director42025-01-012025-12-3103331962ns10:RegisteredOffice2025-01-012025-12-3103331962ns5:CurrentFinancialInstruments2025-12-3103331962ns5:CurrentFinancialInstruments2024-12-3103331962ns5:ShareCapital2025-12-3103331962ns5:ShareCapital2024-12-3103331962ns5:RetainedEarningsAccumulatedLosses2025-12-3103331962ns5:RetainedEarningsAccumulatedLosses2024-12-3103331962ns10:OrdinaryShareClass12025-12-3103331962ns10:OrdinaryShareClass12024-01-012024-12-31
REGISTERED NUMBER: 03331962 (England and Wales)














Financial Statements

for the Year Ended 31st December 2025

for

Gem Scientific Limited

Gem Scientific Limited (Registered number: 03331962)






Contents of the Financial Statements
for the year ended 31st December 2025




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


Gem Scientific Limited

Company Information
for the year ended 31st December 2025







DIRECTORS: N. A. Bewell
J. J. R. Chapman
I. A. Roulstone
J. Welton



REGISTERED OFFICE: Unit 301
Batley Enterprise Centre
513 Bradford Road
Batley
West Yorkshire
WF17 8LL



REGISTERED NUMBER: 03331962 (England and Wales)



AUDITORS: Sadofskys
Statutory Auditors
Princes House
Wright Street
Hull
East Yorkshire
HU2 8HX



BANKERS: Natwest Bank
1 Victoria Place
Holbeck
Leeds
LS11 5AN

Gem Scientific Limited (Registered number: 03331962)

Abridged Balance Sheet
31st December 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 35,498 45,129

CURRENT ASSETS
Stocks 309,825 266,377
Debtors 2,400,350 2,561,852
Cash at bank and in hand 842,846 645,658
3,553,021 3,473,887
CREDITORS
Amounts falling due within one year 1,055,547 1,032,607
NET CURRENT ASSETS 2,497,474 2,441,280
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,532,972

2,486,409

PROVISIONS FOR LIABILITIES 3,407 8,040
NET ASSETS 2,529,565 2,478,369

CAPITAL AND RESERVES
Called up share capital 5 1,000 1,000
Retained earnings 2,528,565 2,477,369
SHAREHOLDERS' FUNDS 2,529,565 2,478,369

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31st December 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8th May 2026 and were signed on its behalf by:





N. A. Bewell - Director


Gem Scientific Limited (Registered number: 03331962)

Notes to the Financial Statements
for the year ended 31st December 2025

1. STATUTORY INFORMATION

Gem Scientific Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation, is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis;

Plant and machinery - 20% straight line
Lessor machinery - Over the life of the lessee contract

Stocks
Stocks are stated and the lower of cost and estimated selling price less costs to sell, which is equivalent to net realisable value.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in the profit or loss.

Gem Scientific Limited (Registered number: 03331962)

Notes to the Financial Statements - continued
for the year ended 31st December 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial statements.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Gem Scientific Limited (Registered number: 03331962)

Notes to the Financial Statements - continued
for the year ended 31st December 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Transactions in currencies, other than the functional currency of the company, are recorded at the rate of exchange on the date the transaction occurs. Monetary items denominated in other currencies are translated at the rate of exchange prevailing at the end of the reporting period. Exchange differences are taken into account in arriving at the operating result. Non-monetary items that are measured at historic cost in a foreign currency are not retranslated.

Leases
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Pension costs and other post-retirement benefits
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised int he period in which the employee's services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2024 - 11 ) .

Gem Scientific Limited (Registered number: 03331962)

Notes to the Financial Statements - continued
for the year ended 31st December 2025

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1st January 2025 362,571
Additions 13,703
At 31st December 2025 376,274
DEPRECIATION
At 1st January 2025 317,442
Charge for year 23,334
At 31st December 2025 340,776
NET BOOK VALUE
At 31st December 2025 35,498
At 31st December 2024 45,129

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
1,000 Ordinary £1 1,000 1,000

6. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Alan Brocklehurst (Senior Statutory Auditor)
for and on behalf of Sadofskys

7. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is LBO France, a company registered in France (RCS Strasbourg Reg. No. 418354502). The immediate parent company is Gem Scientific 2014 Limited, a company registered in England and Wales (Reg. No. 09304255).

The parent of the largest group for which consolidated financial statements are drawn up is Dutscher Holding. Copies of the consolidated accounts can be obtained from 2C, Rue De Bruxelles, 67170, Bernolsheim, France.

The parent of the smallest group for which consolidated financial statements are drawn up is Scientific Laboratory Supplies Group Limited, whose registered office address is Orchard House, The Square, Hessle, United Kingdom, HU13 0AE.

Dutscher Holding SAS (incorporated in France) is regarded by the directors as being the company's ultimate parent company (RCS Strasbourg Reg. No. 882634660).